Company Filing History:
Years Active: 2015
Title: Yuenan Liu: Innovator in Shiga Toxin Research
Introduction
Yuenan Liu is a prominent inventor based in Shenyang, China. He has made significant contributions to the field of microbiology and epidemiology, particularly in the development of innovative solutions to combat type-2 Shiga toxin.
Latest Patents
Yuenan Liu holds a patent for a polypeptide known as TF1, which is designed to inhibit type-2 Shiga toxin activity. The patent details an encoding gene for this polypeptide and its potential uses in medicine. The polypeptide TF1, also referred to as P1, has an amino acid sequence specified in the sequence list as SEQ ID NO: 1. This invention aims to provide a therapeutic option for preventing and treating diseases caused by type-2 Shiga toxin or the pathogens that produce it.
Career Highlights
Yuenan Liu is affiliated with the Institute of Microbiology and Epidemiology at the Academy of Military Medical Sciences in China. His work focuses on advancing medical research and developing effective treatments for toxin-related diseases.
Collaborations
Yuenan Liu collaborates with notable colleagues, including Hui Wang and Tao Li, who contribute to his research efforts and innovations in the field.
Conclusion
Yuenan Liu's work in developing the polypeptide TF1 represents a significant advancement in the fight against type-2 Shiga toxin. His contributions to microbiology and epidemiology highlight the importance of innovative research in addressing public health challenges.